您的位置: 首页 > 农业专利 > 详情页

Methods and pharmaceutical formulations for treatment of selective estrogen-receptor modulator-induced adverse drug reactions
专利权人:
Limoxifen B.V.
发明人:
Tuiten, Jan Johan Adriaan,Bocker, Konrad Bernardus Everardus,Koppeschaar, Hans Peter Frederik
申请号:
AU2014347357
公开号:
AU2014347357A1
申请日:
2014.11.11
申请国别(地区):
AU
年份:
2016
代理人:
摘要:
The invention related to methods of treatment of an individual suffering from or at risk of suffering from a selective estrogen-receptor modulator (SERM) induced adverse drug reaction. The invention additionally relates to a pharmaceutical dosage form, preferably a tablet, comprising a composition for pulsatile, not-continuous release of a compound or a combination of compounds that stimulate the dopamine and/or the noradrenergic system.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充